BioHealth News Archive
TEDCO Announces $8.5 Million in New Stem Cell Program Awards – Tedco
The Maryland Stem Cell Research Commission (Commission) approved funding for 29 awards for a total of $8,533,987. These awards will be distributed between 6…
Read MoreImmunomic Licenses CMV-Targeting Tech from Annias for LAMP-Vax Cancer Vaccines – GEN
Immunomic Therapeutics negotiated an exclusive license to Annias Immunotherapeutics’ platform covering technology for targeting cytomegalovirus (CMV) antigens in cancer. The CMV immunotherapy platform…
Read MoreGreenspring gathers $595m for latest flagship fund of funds | AltAssets Private Equity News
US venture capital fund of funds Greenspring has hit $595m for its latest flagship fundraise, AltAssets can reveal. The firm has registered the amount…
Read MoreBahija Jallal of MedImmune named 2017 Woman of the Year by the Healthcare Businesswomen’s Association
The Healthcare Businesswomen’s Association (HBA) announced that its 2017 Woman of the Year is Bahija Jallal, PhD, executive vice president, AstraZeneca, and head of…
Read MoreFocus on BioCareers – Thu, May 18, 2017 at 2:00 PM
Yes, we're still going to have networking with a few drinks and snacks as usual! Join us on May 18th in the back lot…
Read MoreUVA, Inova award seed funding grants to joint research teams – Augusta Free Press
The Inova Health System and the University of Virginia announced today that they have awarded $450,000 to nine UVA-Inova joint research teams for projects…
Read MoreBright ideas for Hopkins: Health hackathon, science camp for city kids, free food fridge, and more – Hub
Five proposals submitted this spring to Johns Hopkins' Idea Lab crowdsourcing website will receive funding by virtue of garnering the most support in online…
Read MoreCONNECTpreneur Summer Forum, Tysons Corner, June 13, 2017
The Big Idea CONNECTpreneur Summer Forum Tysons Corner - June 13, 2017 "The Best Networking Event in the MidAtlantic." This will be our 24th…
Read MoreAltimmune, Inc. (Nasdaq: ALT) to Ring The Nasdaq Stock Market Opening Bell – NASDAQ.com
Altimmune, Inc. (Nasdaq:ALT), a clinical stage immunotherapeutic biotechnology company, will visit the Nasdaq MarketSite in Times Square. In honor of the occasion, Bill Enright,…
Read MoreAltimmune Completes Merger with PharmAthene Creating Immunotherapeutics Company Targeting Infectious Diseases Nasdaq:ALT
Altimmune, Inc. (Nasdaq:ALT) announced today the completion of its merger with PharmAthene, Inc., effective May 4, 2017. Upon the completion of the merger, the…
Read MoreHospital Impact: Congress must learn from the past and avoid undermining medical research – FierceHealthcare
What's the definition of "doing the same thing repeatedly and expecting a different result?" If you said "a good idea," you might want to…
Read MoreGreater Washington Partnership Expands Board of Directors
The Greater Washington Partnership (Partnership), a group of leading CEOs and entrepreneurs aimed at addressing the critical economic issues facing the Greater Washington region,…
Read MoreEmergent BioSolutions Unveils Its Expanded Center for Innovation in Advanced Development and Manufacturing in Baltimore NYSE:EBS
Emergent BioSolutions Inc. (NYSE:EBS) today held a ribbon-cutting ceremony led by Dr. Rick Bright, director of the Biomedical Advanced Research and Development Authority (BARDA),…
Read MoreFederal Labs: New Class of FLC Officers Elected at 2017 National Meeting
During the 2017 FLC national meeting in San Antonio, Texas, the FLC held its annual elections for open positions to serve on the Executive…
Read MoreThe long shot: How the region wants to become a top three biotech market by 2023
Business leaders hope to elevate Greater Washington to top three biotech clusters in U.S. Yeah, good luck. {iframe}http://www.bizjournals.com/washington/news/2017/05/12/the-long-shot-how-the-region-wants-to-become-a-top.html{/iframe}
Read More